BAYLOR MEDICAL CENTER-GRAPEVINE — History
CCN 450563 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$360M
Latest Revenue (FY2022)
+6.7%
Revenue CAGR (3yr)
17.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $316M | $358M | $360M | +0.6% | +6.7% |
| Operating Expenses | $257M | $295M | $298M | +1.0% | +7.8% |
| Operating Margin | 18.8% | 17.5% | 17.2% | -2.0% | -4.4% |
| Net Income | $59M | $63M | $62M | -1.4% | +2.0% |
| Licensed Beds | 277 | 277 | 248 | -10.5% | -5.4% |
| Total Patient Days | 61,879 | 67,621 | 60,441 | -10.6% | -1.2% |
| Medicare Day % | 28% | 26% | 31% | +20.3% | +6.2% |
| Medicaid Day % | 1% | 1% | 1% | +20.2% | -5.3% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +13.9% ($316M → $360M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+6.7%
This Hospital
+7.6%
State Avg
Latest Margin
17.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $382M | 16.4% |
| FY2024 (proj) | $404M | 15.6% |
| FY2025 (proj) | $426M | 14.8% |